Literature DB >> 15296996

Results of surgical treatment of sporadic medullary thyroid carcinoma following routine measurement of serum calcitonin.

E Mirallié1, M Iacobone, F Sebag, J F Henry.   

Abstract

AIM: The aim of this study was to evaluate the results of the surgical management of medullary thyroid carcinoma (MTC), following the introduction of systematic calcitonin measurement in patients referred for thyroid diseases.
METHOD: We included all the patients with elevated calcitonin and MTC from January 1993 to March 2001.
RESULTS: Among 8497 patients, MTC was diagnosed in 52 with a mean age of 56.1 years. Thirty-two fine needle biopsies led to diagnose MTC in 19 cases. The median basal pre-operative calcitonin level was 245 pg/ml. Elevated calcitonin serum was the only indicator of MTC in 31 patients. Fifty-one patients underwent total thyroidectomies, with lymphadenectomy in 45. Thirteen patients had lymph node involvement. Post-operatively, 40 (77%) had normal basal and pentagastrin (Pg) stimulated calcitonin serum levels, and remained normal at a mean follow-up of 5.16 years (1.8-8).
CONCLUSION: Routine pre-operative measurement of calcitonin should be performed because it is often the only indicator of MTC at an early stage. This could lead to an improved MTC cure rate.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15296996     DOI: 10.1016/j.ejso.2004.05.016

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  8 in total

1.  Medullary thyroid carcinoma: multivariate analysis of prognostic factors influencing survival.

Authors:  Isabel Peixoto Callejo; José Américo Brito; Carlos Manuel Zagalo; Jorge Rosa Santos
Journal:  Clin Transl Oncol       Date:  2006-06       Impact factor: 3.405

2.  Interest of sentinel node biopsy in apparently intrathyroidal medullary thyroid cancer: a pilot study.

Authors:  M Puccini; G Manca; C Ugolini; V Candalise; A Passaretti; J Bernardini; G Boni; P Buccianti
Journal:  J Endocrinol Invest       Date:  2014-06-21       Impact factor: 4.256

3.  Isthmus-preserving total bilobectomy: an adequate operation for C-cell hyperplasia.

Authors:  Robert Arnulf Wahl; Christian Vorländer; Susanne Kriener; Johanna Pedall; Martin Spitza; Martin-Leo Hansmann
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

4.  Long-Term Outcome After Surgery for Medullary Thyroid Carcinoma: A Single-Center Experience.

Authors:  Francesca Torresan; Elisabetta Cavedon; Caterina Mian; Maurizio Iacobone
Journal:  World J Surg       Date:  2018-02       Impact factor: 3.352

5.  Calcitonin testing for detection of medullary thyroid cancer in people with thyroid nodules.

Authors:  Hans Hg Verbeek; Jan Willem B de Groot; Wim J Sluiter; Anneke C Muller Kobold; Edwin R van den Heuvel; John Tm Plukker; Thera P Links
Journal:  Cochrane Database Syst Rev       Date:  2020-03-16

6.  Sporadic medullary thyroid carcinoma: clinical data from a university hospital.

Authors:  Joya Emilie M Correia-Deur; Rodrigo A Toledo; Alice T Imazawa; Delmar M Lourenço; Marilza C L Ezabella; Marcos R Tavares; Sergio P A Toledo
Journal:  Clinics (Sao Paulo)       Date:  2009-05       Impact factor: 2.365

7.  Investigation of factors potentially influencing calcitonin levels in the screening and follow-up for medullary thyroid carcinoma: a cautionary note.

Authors:  Christoph Guesgen; Arnulf Willms; Axel Zwad; Stephan Waldeck; Helmut Wieler; Robert Schwab
Journal:  BMC Clin Pathol       Date:  2013-11-04

8.  Vandetanib in children and adolescents with multiple endocrine neoplasia type 2B associated medullary thyroid carcinoma.

Authors:  Elizabeth Fox; Brigitte C Widemann; Meredith K Chuk; Leigh Marcus; Alberta Aikin; Patricia O Whitcomb; Maria J Merino; Maya Lodish; Eva Dombi; Seth M Steinberg; Samuel A Wells; Frank M Balis
Journal:  Clin Cancer Res       Date:  2013-06-13       Impact factor: 12.531

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.